Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gnant

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
Expert Review of Anticancer Therapy|December 21, 2012
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibitionMichael Gnant
European Journal of Cancer (Oxford, England : 1990)|August 3, 2019
New evidence and hope for young patients with breast cancerMichael Gnant
World Journal of Surgery|November 19, 2008
To measure the unmeasurableMichael Gnant
Nature Reviews. Clinical Oncology|November 9, 2011
Targeted therapies: adjuvant bisphosphonates--an option with low estrogen?Michael Gnant
Breast Care (Basel, Switzerland)|January 14, 2014
Guidelines: usefulness and limitationsMichael Gnant
Current Opinion in Oncology|October 9, 2012
Adjuvant bisphosphonates: a new standard of care?Michael Gnant
The Lancet. Oncology|December 4, 2010
10 years of ATAC: one question answered, many others unresolvedMichael Gnant
Oncotargets and Therapy|July 10, 2010
The evolving role of zoledronic acid in early breast cancerMichael Gnant
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
[Neoadjuvant treatment and breast conserving surgery - a success of clinical research in breast cancer]Michael Gnant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Can oral bisphosphonates really reduce the risk of breast cancer in healthy women?Michael Gnant
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
Expert Review of Anticancer Therapy|December 21, 2012
Overcoming endocrine resistance in breast cancer: importance of mTOR inhibitionMichael Gnant
European Journal of Cancer (Oxford, England : 1990)|August 3, 2019
New evidence and hope for young patients with breast cancerMichael Gnant
World Journal of Surgery|November 19, 2008
To measure the unmeasurableMichael Gnant
Nature Reviews. Clinical Oncology|November 9, 2011
Targeted therapies: adjuvant bisphosphonates--an option with low estrogen?Michael Gnant
Breast Care (Basel, Switzerland)|January 14, 2014
Guidelines: usefulness and limitationsMichael Gnant
Current Opinion in Oncology|October 9, 2012
Adjuvant bisphosphonates: a new standard of care?Michael Gnant
The Lancet. Oncology|December 4, 2010
10 years of ATAC: one question answered, many others unresolvedMichael Gnant
Oncotargets and Therapy|July 10, 2010
The evolving role of zoledronic acid in early breast cancerMichael Gnant
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
[Neoadjuvant treatment and breast conserving surgery - a success of clinical research in breast cancer]Michael Gnant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Can oral bisphosphonates really reduce the risk of breast cancer in healthy women?Michael Gnant
Pageof 33